Nevertheless, compared with the sole use of Sor, the co-administration of PF and Sor in tumor-bearing mice significantly enhanced the infiltration of CD4+ T cells in tumor tissues, while reversing the inhibition of CD8+ T cell infiltration and reversing the IL-2 depletion induced by Sor. The gene discussed is CD4; the disease is neoplasm.